ICU Medical, Nexus Medical Bolster $1.8 Billion U.S.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ICU Medical, Nexus Medical Bolster $1.8 Billion U.S. Infusion Therapy Market with Anti-Reflux Technology

VANCOUVER, BC, Jan. 14, 2015 (GLOBE NEWSWIRE) -- via PRWEB - According to a new report by iData Research , in light of recent infusion pump product recalls, there has been a shift towards neutral displacement needleless connectors. This shift has been driven by companies like Nexus Medical and ICU Medical, with neutral displacement devices that incorporate anti-reflux technology.

"The infusion therapy device market has been disrupted by product recalls affecting a significant proportion of installed base units," explains Dr. Kamran Zamanian, CEO of iData. "However, newer pump systems that incorporate additional features, such as wireless capabilities and anti-reflux technology, will enhance patient safety and drive growth."

Other key findings from the 2015 edition of the iData Research report entitled U.S. Market for Infusion Therapy Devices :

  • Product Recalls: These product issues surrounding the recall have not only raised concerns about available infusion pumps, but have also put pressure on the device supply chain; infusion therapies are a significant element of medical treatment in the U.S. and at times must be replaced in high unit volumes when a recall is issued.
  • Syringe Pump Market Growth: While other markets are facing competition from alternative treatments, the syringe pump market has a niche application in the neonatal intensive care unit and OR settings. Market growth is expected to continue through 2021 as analysed in this report.
  • IV Fluid Shortage: Shortages of hydration fluids have required companies to import additional supplies from their manufacturing facilities abroad. This has led to a slight shift towards the use of extension IV sets at the expense of primary IV sets, further moderating market growth.
ICU Medical was the leading competitor in the U.S. needleless connector market in 2014. They are one of the few companies in this market that uses anti-reflux technology. Long-term growth will be driven by the switch to devices that incorporate anti-reflux technology. Increasing use of neutral displacement connectors is leading to an appreciation in overall market ASP. For Further Information
This in-depth market analysis is from a new 2015 edition report published by iData entitled " U.S. Market for Infusion Therapy Devices ", which covers the U.S. infusion therapy market as a whole, as well as market sub-segments for the following:
  • Large Volume Infusion Pumps
  • Syringe Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Electronic Ambulatory Infusion Pumps
  • Disposable Ambulatory Infusion Pumps
  • Disposable Ambulatory Infusion Non-Pain Pump
  • Surgical Post-Operative Disposable Ambulatory Infusion Pain Pump
  • Peripheral Nerve Block Disposable Ambulatory Infusion Pain Pump
  • Dedicated Pump Primary IV Set
  • Non-Dedicated Primary IV Set
  • Secondary IV Set
  • IV Extension Set
  • Split Septum and Blunt Cannula
  • Mechanical Valve Needleless Connector
  • Negative Displacement Mechanical Valve Needleless Connector
  • Positive Displacement Mechanical Valve Needleless Connector
  • Neutral Displacement Mechanical Valve Needleless Connector
  • Anti-Reflux Neutral Displacement Mechanical Valve Needleless Connector

The global series on the infusion therapy device market covers 19 countries, including the U.S., Japan, South Korea, Australia, and 15 countries in Europe.

The full reports provide a comprehensive analysis including units sold, procedure numbers, market values, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment.

Register online or email us at info(at)idataresearch(dot)net for a U.S. Market for Infusion Therapy Devices report brochure and synopsis.

About iData Research
iData Research ( http://www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/01/prweb12443462.htm

iData Research Caroline Lau +1 604-266-6933 Ext: 215

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 198

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 163

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 410

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Globant's 2025 Q1 Revenue Growth and Strategic Focus

Updated Category News Views 873

Globant's Remarkable Financial Performance for Q1 2025 Globant (NYSE: GLOB), a leader in technology-enabled business transformation, has reported a strong performance for the first quarter of 2025. The company achieved revenues of $611.1 million, marking a 7.0% increase compared to the same period last year. This notable growth reflects Globant's commitment to leveraging...

Continue Reading
Transforming Rehabilitation: The Future of Medical Exoskeletons

Updated Category News Views 329

Explosive Growth in the Medical Exoskeleton Market The global medical exoskeleton market is experiencing remarkable growth, projected to reach a value increase of USD 2.87 billion during the upcoming period from 2024 to 2028. A crucial driving force behind this surge is the rising number of spinal cord injury (SCI) cases, coupled with advancements in artificial...

Continue Reading
Exclusive Elks Hoop Shoot Champions Honored at Hall of Fame

Updated Category News Views 167

Celebrating Youth Basketball Talent The spirit of perseverance and hard work was palpable as the finest youth free-throw shooters gathered at Wintrust Arena, illustrating their dedication to the game. Recently, the Elks Hoop Shoot competition showcased young athletes' skills and determination as they vied for national titles in three age groups for both boys and girls....

Continue Reading
Key Insights for Cepton, Inc. Investors Regarding Legal Actions

Updated Category News Views 190

Understanding Your Legal Rights as a Cepton, Inc. Investor Cepton, Inc. (NASDAQ: CPTN) has recently come under scrutiny, attracting the attention of investors concerned about potential securities fraud. As such, it is crucial for shareholders to be informed about their rights and options as they navigate these turbulent waters. Recent developments suggest that investors...

Continue Reading
Teamsters at Seattle Airport Vote to Strike Against Swissport

Updated Category News Views 283

Teamsters at Seattle Airport Take Bold Action In a significant move toward ensuring safe and fair labor practices, air fuelers at Seattle-Tacoma International Airport have voted unanimously to authorize a strike against Swissport, a leading provider of ground services in the aviation industry. With over 150 workers represented by Teamsters Local 174, this decision stems...

Continue Reading